Role of Vitamin D And Calcium supplementation on breast cancer receiving chemotherapy
Not Applicable
- Conditions
- Health Condition 1: C509- Malignant neoplasm of breast of unspecified siteHealth Condition 2: C501- Malignant neoplasm of central portion of breastHealth Condition 3: C500- Malignant neoplasm of nipple and areolaHealth Condition 4: C508- Malignant neoplasm of overlappingsites of breast
- Registration Number
- CTRI/2022/03/040878
- Lead Sponsor
- King George Medical University UP
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Naïve Stage II/III breast cancer patients consenting for NACT.
Exclusion Criteria
1. Patients with osteoporosis and parathyroid disorders.
2. Patients not consenting for chemotherapy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate the effect of vitamin d and calcium on tumor response by supplementing it during neoadjuvant chemotherapy in breast cancerTimepoint: at the end of 4 cycles of chemotherapy
- Secondary Outcome Measures
Name Time Method To evaluate the effect of Vitamin D and calcium supplementation during chemotherapy in breast cancer patients on <br/ ><br> <br/ ><br>Neutrophil to lymphocytes ratio [NLR] <br/ ><br> Amelioration of toxic side effects <br/ ><br> quality of Life.Timepoint: at the end of 4 cycles of chemotherapy